ABVC — ABVC Biopharma Share News
0.000.00%
Last trade - 00:00Brief: FDA Approves IND Submission Allowing ABVC Biopharma To Proceed With Clinical Study Of Abv-1519 To Treat Non-Small Cell Lung Cancer
ABVC BioPharma surges on FDA nod to start lung cancer drug trial
Brief: ABVC BioPharma Provides Vitargus Update Of Phase II Vitargus Study Protocol Received Thai FDA Approval
Abvc Biopharma Inc Reports Results For The Quarter Ended In September: Earnings Summary
Brief: ABVC BioPharma Reports Third Quarter 2022 Financial, Operational Results
Abvc Biopharma Inc Expected To Post A Loss Of 12 Cents A Share: Earnings Preview
Brief: ABVC Biopharma Receives Notice Of Allowance From US Patent And Trademark Office For Abv-1504
ABVC rises after positive update on brain disorder drug trial
Brief: ABVC Biopharma Provides ADHD Phase II Part 2 Clinical Study Update
Brief: ABVC Biopharma Inc - To Reappoint Leeds Chow As CFO
Brief: ABVC Biopharma Selects Additional Vitargus® Phase II Study Site
Brief: ABVC Provides Oncology Pipeline Updates
U.S. STOCKS ON THE MOVE-Cisco, Babcock & Wilcox, Snap, Getty Images
U.S. STOCKS ON THE MOVE-Canadian Solar, Applied Materials, Gold and copper miners
ABVC BioPharma up as Thai ethics committee allows eye device trial
Brief: ABVC Biopharma provides Vitargus® update
Abvc Biopharma Inc Reports Results For The Quarter Ended In March: Earnings Summary
Brief: ABVC BioPharma Reports Q2 2022 Results
Abvc Biopharma Inc Expected To Post A Loss Of 20 Cents A Share: Earnings Preview